Oxidative stress in developmental brain disorders
- PMID: 19154320
- DOI: 10.1111/j.1440-1789.2008.00888.x
Oxidative stress in developmental brain disorders
Abstract
Oxidative stress is one of the predisposing factors in adult neurological disorders. We have examined the involvement of oxidative stress in child-onset neurodegenerative disorders, and here we review the findings from our analysis. In cases of Cockayne syndrome, the oxidative products of lipids and proteins were increased in the globus pallidus; however, oxidative nucleotide damage that coincided with reduced copper/zinc superoxide dismutase (Cu/ZnSOD) expression was observed in cases of xeroderma pigmentosum, and these patients also presented increased oxidative stress markers in urine samples. In spinal muscular atrophy, lipid peroxidation in conjunction with oxidative DNA damage was observed in motor neurons. Cases of subacute sclerosing panencephalitis presented oxidative nucleoside damage in cerebral cortical neurons at early disease stages, which were subsequently replaced by lipid peroxidation in glial cells of cerebral white matter. In relation to progressive myoclonic epilepsy, oxidative damage to DNA, proteins, and lipids appeared to coincide with cerebral and cerebellar cortical lesions of neuronal ceroid-lipofuscinosis. Patients with Lafora disease also presented an increase in oxidative stress markers for DNA and/or lipids in the brain and urine. These findings imply involvement of oxidative stress in developmental brain disorders; antioxidant agents could prove to be useful for treating patients with those disorders.
Similar articles
-
Oxidative nucleotide damage and superoxide dismutase expression in the brains of xeroderma pigmentosum group A and Cockayne syndrome.Brain Dev. 2005 Jan;27(1):34-8. doi: 10.1016/j.braindev.2004.04.001. Brain Dev. 2005. PMID: 15626539
-
Oxidative stress in developmental brain disorders.Adv Exp Med Biol. 2012;724:278-90. doi: 10.1007/978-1-4614-0653-2_21. Adv Exp Med Biol. 2012. PMID: 22411250 Review.
-
Mechanisms of neurodegeneration in neuronal ceroid-lipofuscinoses.Acta Neuropathol. 2006 Feb;111(2):168-77. doi: 10.1007/s00401-005-0024-x. Epub 2006 Feb 8. Acta Neuropathol. 2006. PMID: 16465529
-
Progressive myoclonic epilepsy: A clinical, electrophysiological and pathological study from South India.J Neurol Sci. 2007 Jan 15;252(1):16-23. doi: 10.1016/j.jns.2006.09.021. Epub 2006 Dec 12. J Neurol Sci. 2007. PMID: 17166519
-
Diagnosis of infantile spasms, Lennox-Gastaut syndrome, and progressive myoclonic epilepsy.Epilepsia. 2004;45 Suppl 5:2-4. doi: 10.1111/j.0013-9580.2004.05002.x. Epilepsia. 2004. PMID: 15283704 Review.
Cited by
-
Xeroderma pigmentosum: overview of pharmacology and novel therapeutic strategies for neurological symptoms.Br J Pharmacol. 2019 Nov;176(22):4293-4301. doi: 10.1111/bph.14557. Epub 2019 Jan 23. Br J Pharmacol. 2019. PMID: 30499105 Free PMC article. Review.
-
Circadian Rhythms of Oxidative Stress Markers and Melatonin Metabolite in Patients with Xeroderma Pigmentosum Group A.Oxid Med Cell Longev. 2016;2016:5741517. doi: 10.1155/2016/5741517. Epub 2016 Apr 26. Oxid Med Cell Longev. 2016. PMID: 27213030 Free PMC article.
-
Selective inhibition of hypoxia-inducible factor (HIF) prolyl-hydroxylase 1 mediates neuroprotection against normoxic oxidative death via HIF- and CREB-independent pathways.J Neurosci. 2009 Jul 8;29(27):8828-38. doi: 10.1523/JNEUROSCI.1779-09.2009. J Neurosci. 2009. PMID: 19587290 Free PMC article.
-
Oxidative stress in the hippocampus during experimental seizures can be ameliorated with the antioxidant ascorbic acid.Oxid Med Cell Longev. 2009 Sep-Oct;2(4):214-21. doi: 10.4161/oxim.2.4.8876. Oxid Med Cell Longev. 2009. PMID: 20716907 Free PMC article.
-
PARP-1 modulates amyloid beta peptide-induced neuronal damage.PLoS One. 2013 Sep 24;8(9):e72169. doi: 10.1371/journal.pone.0072169. eCollection 2013. PLoS One. 2013. PMID: 24086258 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical